NCT02173756 2026-03-16
MorphinOgel
University Hospital, Strasbourg, France
Phase 3 Terminated
Clinical Trials
62 trialsNCT07047456 2025-12-23
Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT
Anhui Provincial Hospital
Phase 3 Recruiting
NCT04447313 2025-11-24
Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study
Fred Hutchinson Cancer Center
Phase 3 Active not recruiting
NCT06940570 2025-10-23
MATCH
University of Texas Southwestern Medical Center
Phase 3 Suspended
NCT05819853 2025-08-28
RESTORE
University of Colorado, Denver
Phase 3 Recruiting
NCT06994507 2025-08-06
GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT01697566 2025-06-11
An Endometrial Cancer Chemoprevention Study of Metformin
M.D. Anderson Cancer Center
Phase 3 Completed
NCT01573442 2025-01-28
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00541047 2023-11-13
RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery
University College, London
Phase 3 Completed
NCT05952882 2023-10-23
Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
Mỹ Đức Hospital
Phase 3 Unknown
NCT01952847 2022-06-15
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT02664441 2022-05-05
ECHO
Seattle Children's Hospital
Phase 3 Completed
NCT00038727 2021-12-28
DPPOS
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 3 Unknown
NCT00612742 2021-10-29
BLOOM
BioSante Pharmaceuticals
Phase 3 Completed
NCT05092113 2021-10-25
The Efficacy and Safety of a Compound Glutamine Capsule in the Primary Prevention of Chemotherapy-induced Mucositis
West China Hospital
Phase 3 Unknown
NCT04988971 2021-10-15
The Efficacy and Safety of a Compound Glutamine Capsule in the Prevention of Chemotherapy-induced Mucositis
West China Hospital
Phase 3 Unknown
NCT03196791 2021-07-12
Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient
Korea University Anam Hospital
Phase 3 Completed
NCT01117051 2021-06-11
OIC
Takeda
Phase 3 Terminated
NCT03480022 2021-06-07
SAXAPCOS
Woman's
Phase 3 Completed
NCT02480114 2021-02-18
Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy
Vanderbilt-Ingram Cancer Center
Phase 3 Completed
NCT02635386 2021-01-29
EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
Woman's
Phase 3 Completed
NCT01758146 2020-03-04
Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3 Unknown
NCT02696408 2020-01-29
STOP MUCITES
Institut de Cancérologie de la Loire
Phase 3 Completed
NCT01305200 2019-09-17
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
Children's Oncology Group
Phase 3 Completed
NCT02091765 2019-08-28
KIS
The Netherlands Cancer Institute
Phase 3 Completed
NCT00615420 2019-06-05
A Randomized Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer
British Columbia Cancer Agency
Phase 3 Completed
NCT00807768 2019-03-20
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
GOG Foundation
Phase 3 Unknown
NCT01376349 2019-02-07
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00020605 2018-12-13
Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01696643 2018-11-15
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Terminated
NCT01901302 2018-11-15
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Terminated
NCT01901328 2018-11-15
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Terminated
NCT01901341 2018-11-15
The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Terminated
NCT00931528 2018-02-14
Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00360971 2017-12-26
Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer
Radiation Therapy Oncology Group
Phase 3 Terminated
NCT00241722 2017-08-30
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Completed
NCT01156142 2017-08-09
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00981305 2017-08-07
Impact of Lactate-Containing Vaginal Lubricant on Sexual Dysfunction in Young Breast Cancer Survivors
Seoul National University Hospital
Phase 3 Completed
NCT01917942 2017-07-12
RadioHum
Trans Tasman Radiation Oncology Group
Phase 3 Completed
NCT01395524 2017-02-23
A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation
AstraZeneca
Phase 3 Completed
NCT00101582 2016-09-27
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer
Swedish Orphan Biovitrum
Phase 3 Completed
NCT00343382 2016-08-12
Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00075855 2016-07-13
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01473290 2016-07-06
Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy
Alliance for Clinical Trials in Oncology
Phase 3 Withdrawn
NCT02282839 2015-11-04
Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation
Taichung Veterans General Hospital
Phase 3 Unknown
NCT01014559 2015-09-28
OXN3505
Mundipharma SAS
Phase 3 Terminated
NCT00256932 2015-09-02
Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Completed
NCT00259922 2015-09-02
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Completed
NCT01323790 2015-06-02
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
AstraZeneca
Phase 3 Completed
NCT01309841 2015-06-01
Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
AstraZeneca
Phase 3 Completed